FDA Drug Safety Podcast: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older
Listen to an audio podcast of the January 11, 2018 FDA Drug Safety Communication requiring safety labeling changes for prescription cough and cold medicines containing codeine or hydrocodone to limit the use of these products to adults 18 years and older because the risks of these medicines outweigh their benefits in children younger than 18. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - June 20, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: podcasts

FDA Drug Safety Podcast: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older
On January 11, 2018, FDA announced that it is requiring safety labeling changes for prescription cough and cold medicines containing codeine or hydrocodone to limit the use of these products to adults 18 years and older because the risks of these medicines outweigh their benefits in children younger than 18. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - January 16, 2018 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts

Should Hydrocodone Be Rescheduled?
A pain expert weighs in on an FDA advisory committee's recent vote in favor of reclassifying hydrocodone-containing medications as schedule II. (Source: Medscape Psychiatry Podcast)
Source: Medscape Psychiatry Podcast - March 20, 2013 Category: Psychiatry Authors: Medscape Source Type: podcasts

Should Hydrocodone Be Rescheduled?
A pain expert weighs in on an FDA advisory committee's recent vote in favor of reclassifying hydrocodone-containing medications as schedule II. (Source: Medscape Neurology Podcast)
Source: Medscape Neurology Podcast - March 20, 2013 Category: Neurology Authors: Medscape Source Type: podcasts